About Diagnosing Africa
Our mission is to increase access to diagnostics, vaccines and other life-saving therapeutics in West Africa and beyond through the transfer of technology and sustainable local production. Our first project would serve as a stepping stone for other subsequent initiatives.
We are currently operating as a registered 501(c)3 corporation that is focused on research and product development of a lateral flow immunoassay for Malaria detection as well as several other febrile causing pathogens. Once assay and process development is complete we would commence the transfer of technology to a Limited Liability Company (LLC) that would be located in Ghana, West Africa.